Metabolic screening and postnatal glucose homeostasis in the newborn.
Pediatr Clin North Am
; 62(2): 385-409, 2015 Apr.
Article
em En
| MEDLINE
| ID: mdl-25836704
ABSTRACT
Although individual metabolic diseases are relatively uncommon, inherited metabolic diseases collectively represent a more common cause of disease in the neonatal period than is generally appreciated. Newborn screening is among the most successful public health programs today. Every day, newborns considered to be at risk for hypoglycemia are screened. The definition of clinically significant hypoglycemia remains among the most confused and contentious issues in neonatology. There are 2 "competing" methods of defining hypoglycemia that suggest very different levels for management one based on metabolic-endocrinologic hormones and another that uses outcome data to determine threshold levels of risk.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Triagem Neonatal
/
Glucose
Tipo de estudo:
Diagnostic_studies
/
Screening_studies
Limite:
Humans
/
Newborn
Idioma:
En
Revista:
Pediatr Clin North Am
Ano de publicação:
2015
Tipo de documento:
Article